This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Amit Madanrao Agarkar
Introduction
Amit Madanrao Agarkar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His innovative work has led to the filing of a patent that showcases his expertise and creativity in the industry.
Latest Patents
Amit Agarkar holds a patent for a process for the preparation of molindone. The patent outlines a detailed method that includes several steps: first, reacting a compound with cyclohexane-1,3-dione to form 2-(2-oxopentan-3-yl)cyclohexane-1,3-dione; second, cyclizing this compound to produce 2-methyl-3-ethyl-4-oxo-4,5,6,7-tetrahydroindole; third, reacting this intermediate with morpholine and formaldehyde to yield molindone; and finally, optionally converting molindone to its salt. This innovative process highlights Agarkar's ability to create valuable pharmaceutical compounds.
Career Highlights
Amit Agarkar is currently associated with Lupin, Inc., a prominent pharmaceutical company known for its commitment to innovation and quality. His work at Lupin has allowed him to contribute to the development of new medications and therapeutic solutions. Agarkar's dedication to his field is evident in his successful patent application and ongoing research efforts.
Collaborations
Amit has collaborated with talented colleagues such as Tejas Vilas Puranik and Rajesh Bharat Gapat. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions in the pharmaceutical sector.
Conclusion
Amit Madanrao Agarkar is a distinguished inventor whose work in the preparation of molindone exemplifies his innovative spirit and dedication to advancing pharmaceutical science. His contributions continue to impact the industry positively, showcasing the importance of creativity and collaboration in research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
